Candesant Biomedical has developed The Brella® SweatControl Patch, which utilizes targeted alkali thermolysis (TAT) to inactivate sweat glands through a non-invasive, topical application. This solution addresses excessive sweating, impacting approximately 84 million adults in the U.S. who seek effective treatment options.
Funding
$64.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KMFounders
Product
Problem
Excessive sweating, or hyperhidrosis, affects a significant portion of the adult population, leading to discomfort, social anxiety, and a reduced quality of life. Current treatment options often present drawbacks such as limited efficacy, the need for frequent re-administration, potential systemic side effects, or significant discomfort. Many patients remain unsatisfied with existing topical treatments, wipes, and oral medications.
Solution
Candesant Biomedical offers the Brella® SweatControl Patch, a non-invasive, single-use topical patch designed to reduce excessive underarm sweating. The patch utilizes targeted alkali thermolysis (TAT) to temporarily inactivate sweat glands through a focused delivery of heat. Applied in a healthcare provider's office in just a few minutes, the bi-layer patch interacts with sweat to create thermal energy, microtargeting the sweat glands. Clinical studies have demonstrated significant sweat reduction and improvements in quality of life measures, with a favorable safety profile. The Brella® patch offers a quick, effective, and non-staining alternative to current hyperhidrosis treatments, fitting easily into existing in-office treatment regimens.
Target Audience
The primary target audience includes individuals affected by excessive underarm sweating (axillary hyperhidrosis) and healthcare providers, such as dermatologists and physicians, seeking an effective and convenient in-office treatment option.
Features
- Topical, non-invasive application in a healthcare provider's office
- Targeted Alkali Thermolysis (TAT) technology for temporary sweat gland inactivation
- Bi-layer patch design for ease of use and focused heat delivery
- Three-minute application time per underarm
- Demonstrated significant reduction in underarm sweat in clinical studies
- Improved quality of life measures, including increased confidence and reduced embarrassment
- Favorable safety profile with minimal downtime
- Single-use and disposable patch